InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Bausch Health Companies Inc.

BHC Clue Score44
Quebec, Canada Fiscal year ends December CIK 0000885590 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

97
Insider
Date
Role
Action
Shares
Price
Amount
Aimee J. Lenar
19 Aug 2026
President, US Pharma
Sold on a plan
36,827
$7.03
$258.89K
Frank D. Lee
19 May 2026
Director
Sold on a plan
24,456
$5.43
$132.80K
Seana Carson
3 Mar 2026
EVP, General Counsel
Sold on a plan
4,420
$5.77
$25.50K
Seana Carson
2 Mar 2026
EVP, General Counsel
Sold on a plan
6,856
$5.78
$39.63K
Seana Carson
27 Feb 2026
EVP, General Counsel
Sold on a plan
8,388
$5.95
$49.91K
Paulson & Co. Inc.
25 Nov 2025
10% owner
Buy indirect
2,500,000
$6.25
$15.63M
Seana Carson
8 Sep 2025
EVP, General Counsel
Sold on a plan
13,370
$7.31
$97.73K
Frank D. Lee
21 Aug 2025
Director
Sell
15,912
$7.66
$121.89K
John Paulson
14 Aug 2025
Director
Buy indirect
34,721,118
$9.00
$312.49M
John Paulson
13 Aug 2025
Director
Buy indirect
86,409
$7.06
$610.05K
John Paulson
12 Aug 2025
Director
Buy indirect
1,156,640
$6.88
$7.96M
John Paulson
11 Aug 2025
Director
Buy indirect
2,000,000
$6.35
$12.70M
John Paulson
13 Jun 2025
Director
Buy indirect
3,564,059
$5.94
$21.17M
John Paulson
12 Jun 2025
Director
Buy indirect
1,005,376
$5.47
$5.50M
John Paulson
11 Jun 2025
Director
Buy indirect
1,029,098
$5.24
$5.39M
John Paulson
10 Jun 2025
Director
Buy indirect
754,134
$5.05
$3.81M
Seana Carson
2 Dec 2024
EVP, General Counsel
Sold on a plan
440
$8.35
$3.67K
Seana Carson
6 Sep 2024
EVP, General Counsel
Sold on a plan
13,370
$6.21
$83.03K
Seana Carson
4 Mar 2024
EVP, General Counsel
Sold on a plan
133
$9.80
$1.30K
Seana Carson
4 Mar 2024
EVP, General Counsel
Sold on a plan
1,561
$9.80
$15.30K
Seana Carson
4 Mar 2024
EVP, General Counsel
Sold on a plan
199
$9.80
$1.95K
Seana Carson
4 Mar 2024
EVP, General Counsel
Sold on a plan
4,420
$9.80
$43.32K
Seana Carson
5 Dec 2023
EVP, General Counsel
Sold on a plan
220
$7.38
$1.62K
Seana Carson
6 Nov 2023
EVP, General Counsel
Sold on a plan
43
$7.61
$327.23
Seana Carson
6 Sep 2023
EVP, General Counsel
Sold on a plan
6,685
$8.28
$55.35K
Seana Carson
28 Feb 2023
EVP, General Counsel
Sell
292
$9.32
$2.72K
Robert Spurr
14 Apr 2022
U.S. President-Pharma Business
Sell
1,595
$22.19
$35.39K
Robert Spurr
15 Mar 2022
U.S. President-Pharma Business
Sell
4,846
$22.20
$107.58K
Joseph F Gordon
8 Mar 2022
Pres&Co-Head Bausch&Lomb/Int'l
Sell
3,889
$21.76
$84.62K
Robert Spurr
2 Mar 2022
U.S. President-Pharma Business
Sell
1,595
$23.37
$37.28K
Joseph F Gordon
2 Mar 2022
Pres&Co-Head Bausch&Lomb/Int'l
Sell
11,077
$23.37
$258.87K
Joseph F Gordon
1 Mar 2022
Pres&Co-Head Bausch&Lomb/Int'l
Sell
6,338
$23.82
$150.97K
Robert Spurr
15 Feb 2022
U.S. President-Pharma Business
Sell
3,251
$25.02
$81.34K
Robert Spurr
18 Jan 2022
U.S. President-Pharma Business
Sell
3,251
$26.63
$86.57K
Steven D Miller
30 Nov 2021
Director
Buy indirect
10,000
$24.17
$241.70K
Steven D Miller
30 Nov 2021
Director
Buy
50,000
$24.24
$1.21M
Eschenbach Andrew C. Von
5 Aug 2021
Director
Buy
1,400
$25.94
$36.32K
Schutter Richard U De
4 Aug 2021
Director
Buy
10,000
$25.01
$250.12K
Sam Eldessouky
11 Jun 2021
EVP & Chief Financial Officer
Sell
17,000
$31.68
$538.59K
Christina Ackermann
2 Jun 2021
EVP and General Counsel
Sold after exercise
121,198
$31.83
$3.86M
Amy B Wechsler
26 May 2021
Director
Sell
11,037
$31.79
$350.81K
William D. Humphries
4 Dec 2020
President, Ortho-Dermatologics
Sold after exercise
114,055
$19.87
$2.27M
William D. Humphries
27 Nov 2020
President, Ortho-Dermatologics
Sold after exercise
13,663
$19.63
$268.21K
William D. Humphries
24 Nov 2020
President, Ortho-Dermatologics
Sold after exercise
21,658
$19.63
$425.20K
William D. Humphries
23 Nov 2020
President, Ortho-Dermatologics
Sold after exercise
1,483
$19.63
$29.12K
William D. Humphries
8 Sep 2020
President, Ortho-Dermatologics
Sell
5,667
$16.17
$91.64K
ValueAct Holdings, L.P.
5 Jun 2020
Director
Buy indirect
948,353
$19.24
$18.25M
ValueAct Holdings, L.P.
5 Jun 2020
Director
Sell indirect
948,353
$19.24
$18.25M
John Paulson
14 May 2020
Director
Buy indirect
585,100
$15.92
$9.31M
John Paulson
14 May 2020
Director
Buy indirect
624,900
$15.87
$9.92M
John Paulson
14 May 2020
Director
Buy indirect
70,000
$15.65
$1.10M
John Paulson
14 May 2020
Director
Buy indirect
348,920
$15.85
$5.53M
John Paulson
13 May 2020
Director
Buy indirect
645,844
$16.70
$10.79M
John Paulson
13 May 2020
Director
Buy indirect
80,300
$16.58
$1.33M
John Paulson
13 May 2020
Director
Buy indirect
603,900
$16.32
$9.86M
John Paulson
12 May 2020
Director
Buy indirect
799,900
$17.24
$13.79M
John Paulson
12 May 2020
Director
Buy indirect
678,400
$17.47
$11.85M
John Paulson
12 May 2020
Director
Buy indirect
374,836
$17.33
$6.50M
John Paulson
12 May 2020
Director
Buy indirect
162,900
$17.50
$2.85M
John Paulson
12 May 2020
Director
Buy indirect
25,000
$17.30
$432.50K
Thomas W. Ross Sr.
12 Mar 2020
Director
Buy
2,500
$15.54
$38.84K
Schutter Richard U De
10 Mar 2020
Director
Buy indirect
3,800
$18.26
$69.38K
Eschenbach Andrew C. Von
10 Mar 2020
Director
Buy
1,100
$18.18
$20.00K
Christina Ackermann
10 Mar 2020
EVP and General Counsel
Buy
4,390
$18.25
$80.11K
Schutter Richard U De
3 Mar 2020
Director
Buy
5,000
$23.08
$115.42K
Joseph C Papa
13 Sep 2019
Chairman & CEO
Buy
30,000
$23.31
$699.30K
Mark C. McKenna
19 Aug 2019
President, Salix
Sell
10,773
$21.83
$235.22K
William D. Humphries
16 Aug 2019
President, Ortho-Dermatologics
Buy
30,703
$21.18
$650.14K
Christina Ackermann
12 Aug 2019
EVP and General Counsel
Sell
3,418
$22.45
$76.73K
Christina Ackermann
11 Jul 2019
EVP and General Counsel
Sell
3,968
$24.81
$98.45K
Joseph C Papa
28 Feb 2019
Chairman & CEO
Buy
30,000
$23.67
$710.10K
Thomas Appio
14 Dec 2018
Pres&Co-Head Bausch&Lomb/Int'l
Buy
25,440
$22.96
$584.02K
Christina Ackermann
16 Oct 2018
EVP and General Counsel
Sell
4,542
$25.50
$115.82K
Christina Ackermann
15 Oct 2018
EVP and General Counsel
Sell
15,404
$24.83
$382.48K
Joseph C Papa
14 Sep 2018
Chairman & CEO
Buy
30,000
$22.32
$669.60K
Paul Herendeen
14 Sep 2018
EVP and CFO
Buy
10,000
$22.61
$226.10K
Schutter Richard U De
13 Sep 2018
Director
Buy
125,000
$23.96
$3.00M
Schutter Richard U De
15 May 2018
Director
Buy
15,000
$21.83
$327.45K
Schutter Richard U De
15 May 2018
Director
Buy indirect
10,000
$21.80
$218.00K
Joseph C Papa
13 Mar 2018
Chairman & CEO
Buy
30,000
$16.05
$481.50K
Paul Herendeen
13 Mar 2018
EVP and CFO
Buy
15,000
$16.10
$241.47K
Schutter Richard U De
8 Mar 2018
Director
Buy
10,000
$15.34
$153.40K
John Paulson
6 Mar 2018
Director
Buy indirect
7,066,629
$15.40
$108.83M
John Paulson
6 Mar 2018
Director
Sell indirect
7,066,629
$15.40
$108.83M
Schutter Richard U De
17 Nov 2017
Director
Buy
10,000
$14.33
$143.30K
John Paulson
16 Nov 2017
Director
Sell indirect
344,216
$14.39
$4.95M
John Paulson
16 Nov 2017
Director
Buy indirect
344,216
$14.40
$4.96M
Schutter Richard U De
21 Aug 2017
Director
Buy
4,900
$14.35
$70.32K
Schutter Richard U De
21 Aug 2017
Director
Buy
5,100
$14.31
$72.98K
Schutter Richard U De
11 May 2017
Director
Buy
20,000
$13.90
$278.00K
Schutter Richard U De
15 Mar 2017
Director
Buy
10,000
$10.80
$108.00K
ValueAct Holdings, L.P.
14 Mar 2017
Director
Buy indirect
2,500,000
$10.81
$27.03M
ValueAct Holdings, L.P.
14 Mar 2017
Director
Buy indirect
500,000
$10.88
$5.44M
Paul Herendeen
14 Mar 2017
EVP and CFO
Buy
24,000
$10.72
$257.28K
Pershing Square Capital Management, L.P.
13 Mar 2017
Director
Sell indirect
18,114,432
$11.00
$199.26M
Thomas W. Ross Sr.
14 Dec 2016
Director
Buy
5,000
$14.73
$73.65K
Pershing Square Capital Management, L.P.
12 Dec 2016
Director
Sell indirect
3,476,690
$14.85
$51.63M

What was left out

Form 4 filings counted 539
Amendments (4/A) skipped 22
Filings about a different issuer 2
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 5
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 18,345,887
Sales filed before the plan box existed 22
History held since 5 Jan 2010